You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,569,230


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,569,230
Title:Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
Abstract:The present invention provides compositions and stable liquid formulations comprising alpha adrenergic receptor antagonists and use thereof for increasing blood flow. In one embodiment, the stable liquid formulations of this invention are useful for reversing the effects of an anesthetic agent, preferably a long-lasting local anesthetic agent administered in conjunction with an alpha adrenergic receptor agonist.
Inventor(s): Chen; Andrew X (San Diego, CA), Knowles; Julius (Del Mar, CA), Weber; Eckard (San Diego, CA)
Assignee: Novalar Pharmaceuticals, Inc. (San Diego, CA)
Application Number:11/611,504
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form; Device;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,569,230

Introduction

Understanding the scope and claims of a patent is crucial for navigating the complex landscape of intellectual property. This analysis will delve into the specifics of United States Patent 7,569,230, exploring its claims, scope, and the broader patent landscape it operates within.

Patent Overview

United States Patent 7,569,230, hereafter referred to as the '230 patent, is a patent that has been granted for a specific invention. To analyze this patent, we need to consider several key aspects:

Invention Disclosure

The '230 patent discloses an invention that must be clearly described in the specification and claims. The invention's disclosure is the foundation upon which the patent's validity and scope are determined[5].

Claims Analysis

Independent and Dependent Claims

Patent claims are the legal boundaries of what the patent protects. Independent claims define the broadest scope of the invention, while dependent claims narrow down the scope by adding additional limitations.

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are critical in determining the patent's scope and are often the focus of infringement and validity analyses[3].
  • Dependent Claims: These claims build upon the independent claims by adding specific features or limitations. They help to further define the invention and can provide additional protection against infringement.

Claim Language and Scope

The language used in the claims is pivotal. Broader claims can encompass a wider range of embodiments but may face challenges related to validity and enforceability. Narrower claims, while more specific, may offer stronger protection but cover a smaller scope of the invention[3].

Patent Scope

Patent Scope Metrics

Researchers have proposed metrics to measure patent scope, such as independent claim length and independent claim count. These metrics can help in assessing the breadth and clarity of the patent claims. For instance, narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Forward Citations and Patent Maintenance

The number of forward citations (citations by later patents) and patent maintenance payments can also indicate the scope and importance of the patent. Patents with more forward citations and higher maintenance payments often have broader and more valuable scopes[3].

Patent Landscape

Related Patents and Continuations

The '230 patent may be part of a larger family of patents, including continuations, continuations-in-part, and divisional applications. Understanding these relationships is essential for determining the overall scope and potential overlaps with other patents. For example, the Cellect case highlights how multiple patents within a family can claim priority from a single application and impact the patent term adjustment[1].

Obviousness-Type Double Patenting (ODP)

ODP is a critical consideration when dealing with multiple related patents. The USPTO must perform an ODP analysis to ensure that the claims of the '230 patent do not overlap with those of other patents in the same family, thereby preventing the extension of patent term beyond what is legally permissible[1].

Legal and Policy Considerations

Reissue Patents

If the '230 patent undergoes reissue, the new claims must comply with 35 U.S.C. § 251, which requires that the reissue claims be directed to the invention disclosed in the original patent. This ensures that the reissue does not broaden the scope of the original invention beyond what was intended[5].

Small Claims Patent Court

The concept of a small claims patent court, currently under study by the Administrative Conference of the United States (ACUS), could impact the enforcement and litigation landscape for patents like the '230 patent. Such a court would aim to provide a more efficient and cost-effective way to resolve patent disputes, particularly for smaller entities[2].

Practical Implications

Infringement and Litigation

Understanding the scope and claims of the '230 patent is crucial for determining potential infringement. Companies must ensure that their products or processes do not infringe on the protected claims. Litigation often revolves around the interpretation of these claims, making their clarity and specificity paramount[4].

Licensing and Collaboration

The scope of the '230 patent also affects licensing agreements and collaborative efforts. Broader patents may offer more comprehensive protection but could be more challenging to license due to their broader claims. Narrower patents, while easier to license, may not offer the same level of protection[3].

Key Takeaways

  • Claims Analysis: Independent and dependent claims define the patent's scope and are critical for determining validity and infringement.
  • Patent Scope Metrics: Metrics like independent claim length and count can help assess the breadth and clarity of the patent.
  • Related Patents: Understanding the family of patents and continuations is essential for determining the overall scope and potential overlaps.
  • Legal Considerations: Compliance with laws such as ODP and reissue requirements is crucial for maintaining the patent's validity.
  • Practical Implications: The scope and claims of the patent significantly impact infringement, litigation, licensing, and collaboration.

FAQs

Q1: What are the key components of a patent claim? A1: The key components include independent claims that define the broadest scope of the invention and dependent claims that narrow down the scope by adding specific features or limitations.

Q2: How does the scope of a patent impact its enforceability? A2: A broader patent scope can make the patent more susceptible to validity challenges but offers wider protection. A narrower scope provides stronger protection but covers fewer embodiments.

Q3: What is obviousness-type double patenting (ODP)? A3: ODP is a legal principle that prevents the extension of patent term by ensuring that multiple related patents do not overlap in their claims.

Q4: How does a reissue patent affect the original patent's scope? A4: A reissue patent must comply with 35 U.S.C. § 251, ensuring that the new claims are directed to the invention disclosed in the original patent and do not broaden the scope beyond what was intended.

Q5: What is the potential impact of a small claims patent court on patent enforcement? A5: A small claims patent court could provide a more efficient and cost-effective way to resolve patent disputes, particularly beneficial for smaller entities.

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. U.S. Patent Small Claims Court, Administrative Conference of the United States.
  3. Patent Claims and Patent Scope, SSRN, September 29, 2016.
  4. Patent Law in the United States, BitLaw.
  5. In Re FLOAT'N'GRILL LLC, Court of Appeals for the Federal Circuit, July 12, 2023.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,569,230

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,569,230

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2003247568 ⤷  Subscribe
Brazil 0311965 ⤷  Subscribe
Brazil PI0311965 ⤷  Subscribe
Canada 2489526 ⤷  Subscribe
China 100391460 ⤷  Subscribe
China 1688312 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.